Importantly, upregulation of TIM‐3 on TIDC has been reported in lung, bladder, and breast cancer patients,61, 62, 63 and multiple mechanisms of DC immunosuppression are mediated by TIM‐3 within the TME. The gene discussed is HAVCR2; the disease is breast cancer.